These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18653628)

  • 1. Synergistic benefit in inflammatory arthritis by targeting I kappaB kinase epsilon and interferon beta.
    Corr M; Boyle DL; Ronacher L; Flores N; Firestein GS
    Ann Rheum Dis; 2009 Feb; 68(2):257-63. PubMed ID: 18653628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1 receptor antagonist mediates the beneficial effects of systemic interferon beta in mice: implications for rheumatoid arthritis.
    Corr M; Boyle DL; Ronacher LM; Lew BR; van Baarsen LG; Tak PP; Firestein GS
    Ann Rheum Dis; 2011 May; 70(5):858-63. PubMed ID: 21216819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IKKε aggravates inflammatory response via activation of NF-κB in rheumatoid arthritis.
    Zhou LF; Zeng W; Sun LC; Wang Y; Jiang F; Li X; Zheng Y; Wu GM
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2126-2133. PubMed ID: 29687872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis.
    Hammaker D; Boyle DL; Firestein GS
    Rheumatology (Oxford); 2012 Apr; 51(4):610-8. PubMed ID: 21613249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral gene expression in rheumatoid arthritis: role of IKKepsilon and interferon regulatory factor 3.
    Sweeney SE; Mo L; Firestein GS
    Arthritis Rheum; 2007 Mar; 56(3):743-52. PubMed ID: 17328045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with recombinant interferon-beta reduces inflammation and slows cartilage destruction in the collagen-induced arthritis model of rheumatoid arthritis.
    van Holten J; Reedquist K; Sattonet-Roche P; Smeets TJ; Plater-Zyberk C; Vervoordeldonk MJ; Tak PP
    Arthritis Res Ther; 2004; 6(3):R239-49. PubMed ID: 15142270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDX19 Inhibits Type I Interferon Production by Disrupting TBK1-IKKε-IRF3 Interactions and Promoting TBK1 and IKKε Degradation.
    Zhang K; Zhang Y; Xue J; Meng Q; Liu H; Bi C; Li C; Hu L; Yu H; Xiong T; Yang Y; Cui S; Bu Z; He X; Li J; Huang L; Weng C
    Cell Rep; 2019 Jan; 26(5):1258-1272.e4. PubMed ID: 30699353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of matrix metalloproteinase and aggrecanase mediated release of latent cytokines at arthritic joints.
    Mullen L; Adams G; Foster J; Vessillier S; Köster M; Hauser H; Layward L; Gould D; Chernajovsky Y
    Ann Rheum Dis; 2014 Sep; 73(9):1728-36. PubMed ID: 23813971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of interferon regulatory factor 7 in serum-transfer arthritis: regulation of interferon-β production.
    Sweeney SE; Corr M; Kimbler TB
    Arthritis Rheum; 2012 Apr; 64(4):1046-56. PubMed ID: 22076939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel inhibitor of I-kappaB kinase beta ameliorates experimental arthritis through downregulation of proinflammatory cytokines in arthritic joints.
    Tanaka S; Toki T; Yokoyama M; Shimizu H; Yamasaki T; Yoneda Y; Muro F; Yasukochi T; Iimura S; Morishita K
    Biol Pharm Bull; 2014; 37(1):87-95. PubMed ID: 24389485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of synovial signalling and gene expression in animal models of arthritis.
    Fukushima A; Boyle DL; Corr M; Firestein GS
    Ann Rheum Dis; 2010 May; 69(5):918-23. PubMed ID: 19473996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Effects of a TANK-Binding Kinase 1 Inhibitor in Germinal Center-Driven Collagen-Induced Arthritis.
    Louis C; Ngo D; D'Silva DB; Hansen J; Phillipson L; Jousset H; Novello P; Segal D; Lawlor KE; Burns CJ; Wicks IP
    Arthritis Rheumatol; 2019 Jan; 71(1):50-62. PubMed ID: 30009417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of molecular imaging to quantify response to IKK-2 inhibitor treatment in murine arthritis.
    Izmailova ES; Paz N; Alencar H; Chun M; Schopf L; Hepperle M; Lane JH; Harriman G; Xu Y; Ocain T; Weissleder R; Mahmood U; Healy AM; Jaffee B
    Arthritis Rheum; 2007 Jan; 56(1):117-28. PubMed ID: 17195214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon beta stimulates interleukin 1 receptor antagonist production in human articular chondrocytes and synovial fibroblasts.
    Palmer G; Mezin F; Juge-Aubry CE; Plater-Zyberk C; Gabay C; Guerne PA
    Ann Rheum Dis; 2004 Jan; 63(1):43-9. PubMed ID: 14672890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF-3 activation pathways.
    Huang J; Liu T; Xu LG; Chen D; Zhai Z; Shu HB
    EMBO J; 2005 Dec; 24(23):4018-28. PubMed ID: 16281057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 2 controls acute immune complex-driven arthritis in mice by regulating the inhibitory Fcγ receptor IIB.
    Abdollahi-Roodsaz S; Koenders MI; Walgreen B; Bolscher J; Helsen MM; van den Bersselaar LA; van Lent PL; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2013 Oct; 65(10):2583-93. PubMed ID: 23860661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the protein kinase IKKepsilon attenuates neuropathic pain in mice.
    Möser CV; Möller M; Fleck SC; Thomas D; Geisslinger G; Niederberger E
    Neuropharmacology; 2019 Mar; 146():198-211. PubMed ID: 30528326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.
    Breiman A; Grandvaux N; Lin R; Ottone C; Akira S; Yoneyama M; Fujita T; Hiscott J; Meurs EF
    J Virol; 2005 Apr; 79(7):3969-78. PubMed ID: 15767399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus polymerase inhibits RIG-I- and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1/IKKepsilon and DDX3.
    Yu S; Chen J; Wu M; Chen H; Kato N; Yuan Z
    J Gen Virol; 2010 Aug; 91(Pt 8):2080-2090. PubMed ID: 20375222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.